Lexaria Bioscience Corp. - *W EXP 01/14/202 (LEXXW)

CUSIP: 52886N117

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / *W EXP 01/14/202
Total 13F shares
591,760
Share change
-88,755
Total reported value
$593,000
Price per share
$0.70
Number of holders
5
Value change
-$61,717
Number of buys
1
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 52886N117?
CUSIP 52886N117 identifies LEXXW - Lexaria Bioscience Corp. - *W EXP 01/14/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Lexaria Bioscience Corp. - *W EXP 01/14/202 (LEXXW) as of Q2 2022

As of 30 Jun 2022, Lexaria Bioscience Corp. - *W EXP 01/14/202 (LEXXW) was held by 5 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 591,760 shares. The largest 5 holders included SABBY MANAGEMENT, LLC, Empery Asset Management, LP, BOOTHBAY FUND MANAGEMENT, LLC, CVI Holdings, LLC, and UBS Group AG. This page lists 5 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.